Extract from the Register of European Patents

EP Citations: EP2784092

Cited inSearch
Type:Patent literature
Publication No.:WO2009134776  [XY]
 (ABBOTT LAB et al.) [X] 1-5,12-15 * pages 16-17 * * tables 69-72 * * claims 1-39 * * sequences 243-244 *[Y] 6-11
Type:Patent literature
Publication No.:EP2316484  [Y]
 (SAMSUNG ELECTRONICS CO LTD et al.) [Y] 6-11 * examples 1-6 * * claims 1-15 *
Type:Patent literature
Publication No.:WO2012069557  [A]
 (GLAXO GROUP LTD et al.) [A] 1-15 * examples 1-16 * * table 5 * * claims 1-16 *
Type:Non-patent literature
Publication information:[A]   CARTER P: "IMPROVING THE EFFICACY OF ANTIBODY-BASED CANCER THERAPIES", NATURE REVIEWS. CANCER, NATUR PUBLISHING GROUP, LONDON, GB, vol. 1, no. 2, 1 November 2001 (2001-11-01), pages 118 - 129, XP009033015, ISSN: 1474-175X, DOI: 10.1038/35101072 [A] 1-15 * figure 1 *
DOI: http://dx.doi.org/10.1038/35101072
Type:Non-patent literature
Publication information:[A]   KARI ALITALO: "The lymphatic vasculature in disease", NATURE MEDICINE, vol. 17, no. 11, 7 November 2011 (2011-11-07), pages 1371 - 1380, XP055149482, ISSN: 1078-8956, DOI: 10.1038/nm.2545 [A] 1-15 * figure 4 *
DOI: http://dx.doi.org/10.1038/nm.2545
Type:Non-patent literature
Publication information:[A]   DATABASE Geneseq [online] 25 November 2010 (2010-11-25), "Human fms-related tyrosine kinase 1 (VEGFR-1) protein, SEQ:1.", XP002731861, retrieved from EBI accession no. GSP:AYJ81126 Database accession no. AYJ81126 [A] 1-15 * the whole document *
Cited inExamination
Type:Patent literature
Publication No.:WO2012162561